Global Blood Therapeutics, Inc.

Not Just About COVID-19 Vaccines In previews of third-quarter earnings season for life science companies, the two hot topics were expected to be high expectations of GLP-1 agonist sales for diabete

The investment firm Starboard Value acquired a $1bn stake in Pfizer Inc. with a goal of turning the company around, but whether an activist investor can pivot the big pharma onto a growth trajectory

Better In Big Pharma? I listened to a discussion recently on the discount rates used to value pharmaceutical and biotechnology products. One of the speakers suggested that the same asset should have a

The biopharma industry remains fundamentally strong despite drug pricing pressure, poor public perception and a challenging two years for the sector financially, according to Biotechnology Innovation